Monaco, March 27, 2025 – QuantifiCare is proud to announce that the new DermaViz UV has been awarded the prestigious Best Aesthetic Device award in 2025, marking our 6th distinction in 10 years of innovation. This year, among more than 1,000 applications, 220...
February 17, 2025 – Quantificare Headquarters Quantificare Announces Transition to LifeViz Neo Quantificare is entering a new era of innovation with LifeViz Neo! As of February 17, 2025, LifeViz App will no longer be maintained. For customers who are no longer under...
Sophia Antipolis, October 23rd, 2024 – QuantifiCare SA, a pioneering company based in Sophia Antipolis and internationally renowned for its expertise in 2D/3D medical imaging and clinical research, is proud to announce the establishment of an AI...
September 18, 2024 QuantifiCare v. Canfield Scientific: German Federal Supreme Court Upholds QuantifiCare’s LifeViz® Infinity Patent On July 23, 2024, the German Federal Supreme Court confirmed the validity of the German part of QuantifiCare’s European patent 3 156...
We are thrilled to announce that QuantifiCare has been featured in the latest issue of Prime Journal, a leading publication for aesthetic medicine professionals. The article highlights the cutting-edge technology behind our 3D LifeViz® systems, with a special focus on...